Browse AMR Genes
Explore antimicrobial resistance genes from the literature
Explore antimicrobial resistance genes from the literature
two-component response regulator
Overview
| Protein Change | Nucleotide Change | Mechanism | Organism | Resistance To | Database | Validation Status |
|---|---|---|---|---|---|---|
| K43E | - | - | Staphylococcus aureus | vancomycin | Reslit | Candidate |
| M54T | - | loss of phosphorylation | Staphylococcus aureus | vancomycin | Reslit | Candidate |
| V14I | - | - | Staphylococcus aureus | vancomycin | Reslit | Candidate |
| R263W | - | - | Staphylococcus aureus | vancomycin | Reslit | Candidate |
| D88Y | - | - | Staphylococcus aureus | vancomycin|daptomycin|dalbavancin | Reslit | Candidate |
Contribution of selected gene mutations to resistance in clinical isolates of vancomycin-intermediate Staphylococcus aureus.
The Role of β-Glycosylated Wall Teichoic Acids in the Reduction of Vancomycin Susceptibility in Vancomycin-Intermediate Staphylococcus aureus.
Environmental conditions dictate differential evolution of vancomycin resistance in Staphylococcus aureus.
Genomic and phenotypic adaptations of methicillin resistant Staphylococcus aureus during vancomycin therapy.